Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study
DOI: http://dx.doi.org/10.25077/jom.7.1.76-81.2022
Author(s)
Elly Usman
(Department of Pharmacology and Therapeutics, Faculty of Medicine, Andalas University)
Abstract
Keywords
Full Text:
PDFReferences
D.H. Tran, R. Sugamata, T. Hirose, S. Suzuki, Y. Noguchi, A. Sugawara, et al, “Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process”, J Antibiot (Tokyo), 2019, 72(10), pp. 759-768.
E. Bosseboeuf, M. Aubry, T. Nhan, J.J. de Pina, J.M. Rolain, D. Raoult, D. Musso, “Azithromycin inhibits the replication of zika virus”, J Antivir Antiretrovir, 2018, 10(1), pp. 6-11.
J.M. Molina, C. Delaugerre, J. Le Goff, B. Mela-Lima, D. Ponscarme, L. Goldwirt, N. de Castro, “No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection”, Med Mal Infect, 2020, 50, pp. 384.
L. Ayerbe, C. Risco-Risco, I. Forgnone, M. Pérez-Piñar, S. Ayis S, “Azithromycin in patients with COVID-19: a systematic review and meta-analysis”, J Antimicrob Chemother, 2022, 77(2), pp. 303-309.
L.B. Bacharier, T.W. Guilbert, D.T. Mauger, et al, “Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial”, JAMA, 2016, 315(4), pp. 419.
L.S. Nguyen, C. Dolladille, M.D. Drici, C. Fenioux, J. Alexandre, J.P. Mira, et al, “Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: An analysis of the world health organization pharmacovigilance database”, Circulation, 2020, 142, pp. 303–305.
P. Gautret, J.C. Lagier, P. Parola, V.T. Hoang, L. Meddeb, M. Mailhe, et al, “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”, Int J Antimicrob Agents, 2020, 105949, pp. 1-6.
Q. Ye, B. Wang, J. Mao, “The pathogenesis and treatment of the `Cytokine Storm' in COVID-19”, J Infect, 2020, 80(6), pp. 607–613.
T. Fiolet, A. Guihur, M. Rebeaud, “Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis”, Clin Microbiol Infect, 2021, 27, pp. 19–27.
T.F. O’Connell, C.J. Bradley, A.E. Abbas et al, “Hydroxychloroquine/azithromycin therapy and QT prolongation in hospitalized patients with COVID-19”, JACC Clin Electrophysiol, 2021, 7, pp. 16–25.
Y. Zhang, J. Dai, H. Jian, J. Lin, “Effects of macrolides on airway microbiome and cytokine of children with bronchiolitis: A systematic review and meta-analysis of randomized controlled trials”, Microbiol Immunol, 2019, 63, pp. 343–349.
Article Metrics
This article has been read : 278 timesPDF file viewed/downloaded : 206 times
Copyright & License
Copyright (c) 2022 Elly Usman
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Undergraduate Program of Midwifery
Faculty of Medicine - Universitas Andalas - Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.